… acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2… The current COVID-19
emergency warrants the urgent … —even if more robust data on antiviral therapies is yet to come. A …

… We randomly assigned inpatients with Covid-19 equally between one of the trial drug … trial
drug and its control (drug available but patient assigned to the same care without that drug). …

… COVID-19, we conducted a review of registered clinical trials. … coronavirus”. We included
interventional clinical trials focusing on patients with COVID-19 and assessing antiviral drugs or …

… start antiviral treatment as soon as possible also for COVID-19 … Combined usage of antiviral
drugs for COVID-19 patients … case; adverse drug reactions and drug-drug interactions should …

… COVID-19 cases in some countries. Since clinical trials to assess the efficacy of available
antivirals for COVID-19 … This review summarizes antiviral drugs that can be potentially used for …

… New antiviral drugs targeting different SARS-CoV-2 … drugs on COVID-19. Experience with
previous virus pandemics has shown us that developing an ample repertoire of antiviral drugs …

… coverage to combat the current COVID-19 crisis as well as emerging coronaviruses with …
the discovery of antiviral drugs for COVID-19, covering the functions of important antiviral targets …

… by the US FDA for treating COVID-19. However, remdesivir’s … antiviral drugs are still urgently
needed. We will discuss the current status of the drug discovery efforts against COVID-19 …

… unprepared drug … antiviral drugs against COVID-19 and explore in the second part reasons
for the frequent negative outcome of these drug trials and the challenges facing antiviral drug …

… sector organizations that have substantial research and development efforts in COVID-19.
We outline key lessons from rapid antiviral drug discovery efforts, or ‘sprints’, and articulate …